S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

OraSure Technologies Stock Forecast, Price & News

+0.30 (+3.25%)
(As of 11/26/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
534,029 shs
Average Volume
925,159 shs
Market Capitalization
$686.52 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive OSUR News and Ratings via Email

Sign-up to receive the latest news and ratings for OraSure Technologies and its competitors with MarketBeat's FREE daily newsletter.

OraSure Technologies logo

About OraSure Technologies

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.


OraSure Technologies (NASDAQ:OSUR) Stock Price Up 4.9%
November 26, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Supplies
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$171.72 million
Book Value
$5.38 per share


Net Income
$-14.92 million
Pretax Margin




Free Float
Market Cap
$686.52 million

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.08 out of 5 stars

Medical Sector

508th out of 1,391 stocks

Surgical & Medical Instruments Industry

50th out of 125 stocks

Analyst Opinion: 3.3Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions

Is OraSure Technologies a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OraSure Technologies stock.
View analyst ratings for OraSure Technologies
or view top-rated stocks.

How has OraSure Technologies' stock price been impacted by Coronavirus (COVID-19)?

OraSure Technologies' stock was trading at $5.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OSUR shares have increased by 61.5% and is now trading at $9.53.
View which stocks have been most impacted by COVID-19

When is OraSure Technologies' next earnings date?

OraSure Technologies is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for OraSure Technologies

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) announced its quarterly earnings results on Wednesday, November, 3rd. The medical instruments supplier reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by $0.16. The medical instruments supplier had revenue of $53.92 million for the quarter, compared to analyst estimates of $47.54 million. OraSure Technologies had a negative trailing twelve-month return on equity of 2.70% and a negative net margin of 4.61%. During the same quarter last year, the firm posted $0.01 earnings per share.
View OraSure Technologies' earnings history

What guidance has OraSure Technologies issued on next quarter's earnings?

OraSure Technologies issued an update on its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $230 million-$233 million, compared to the consensus revenue estimate of $235.90 million.

What price target have analysts set for OSUR?

3 equities research analysts have issued 12 month target prices for OraSure Technologies' shares. Their forecasts range from $12.50 to $20.00. On average, they anticipate OraSure Technologies' share price to reach $15.83 in the next twelve months. This suggests a possible upside of 66.1% from the stock's current price.
View analysts' price targets for OraSure Technologies
or view top-rated stocks among Wall Street analysts.

Who are OraSure Technologies' key executives?

OraSure Technologies' management team includes the following people:
  • Stephen S. Tang, President, Chief Executive Officer & Director
  • James Ted Rauth, Senior Vice President-Operations
  • Scott K. Gleason, CFO, SVP-Investor Relations & Communications
  • Jack E. Jerrett, Secretary, Chief Compliance Officer & Senior VP
  • Kathleen G. Weber, EVP-Business Unit Leader & Molecular Solutions

What is Stephen Tang's approval rating as OraSure Technologies' CEO?

2 employees have rated OraSure Technologies CEO Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among OraSure Technologies' employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OraSure Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

Who are OraSure Technologies' major shareholders?

OraSure Technologies' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (19.06%), Camber Capital Management LP (5.90%), American Capital Management Inc. (5.08%), Dimensional Fund Advisors LP (4.00%), Neuberger Berman Group LLC (2.67%) and Geode Capital Management LLC (1.71%).
View institutional ownership trends for OraSure Technologies

Which institutional investors are selling OraSure Technologies stock?

OSUR stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Jane Street Group LLC, Invesco Ltd., South Dakota Investment Council, Los Angeles Capital Management LLC, Primecap Management Co. CA, and UBS Group AG.
View insider buying and selling activity for OraSure Technologies
or view top insider-selling stocks.

Which institutional investors are buying OraSure Technologies stock?

OSUR stock was bought by a variety of institutional investors in the last quarter, including RTW Investments LP, Camber Capital Management LP, Millennium Management LLC, Marshall Wace LLP, Kornitzer Capital Management Inc. KS, Goldman Sachs Group Inc., Dimensional Fund Advisors LP, and Deutsche Bank AG.
View insider buying and selling activity for OraSure Technologies
or or view top insider-buying stocks.

How do I buy shares of OraSure Technologies?

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OraSure Technologies' stock price today?

One share of OSUR stock can currently be purchased for approximately $9.53.

How much money does OraSure Technologies make?

OraSure Technologies has a market capitalization of $686.52 million and generates $171.72 million in revenue each year. The medical instruments supplier earns $-14.92 million in net income (profit) each year or ($0.15) on an earnings per share basis.

How many employees does OraSure Technologies have?

OraSure Technologies employs 570 workers across the globe.

What is OraSure Technologies' official website?

The official website for OraSure Technologies is www.orasure.com.

Where are OraSure Technologies' headquarters?

OraSure Technologies is headquartered at 220 EAST FIRST STREET, BETHLEHEM PA, 18015.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at (610) 882-1820, via email at [email protected], or via fax at 610-882-1830.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.